FINWIRES · TerminalLIVE
FINWIRES

Research Alert: Pgr Q1 Eps Tops Expectations Despite Challenging Market Conditions

-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:

Progressive posted Q1 operating EPS of $4.96 vs. $4.65 in the prior year, topping our $4.83 estimate and $4.88 consensus, despite earned premium growth of 8% falling short of our 10%-15% forecast. Full-year 2025 earned premiums rose 15%, in line with our forecast, while Q1 written premiums increased 6% with policies-in-force up 9%, indicating growth from exposure rather than pricing. We think PGR's ability to produce above-peer top-line growth and best-in-class underwriting profitability provides the shares with a catalyst. Management offered no commentary as the firm does not hold regular calls. We forecast 8%-12% earned premium growth in 2026, remaining above most peers despite the competitive pricing environment. The Q1 combined ratio of 86.4% vs. 86.0% in the prior year demonstrates continued superior underwriting results vs. industry averages. We keep our Buy rating, as we believe the defensive nature of personal lines insurance and PGR's operational excellence support valuation despite pricing headwinds.

Related Articles

Asia

Shakti Pumps (India) Invests INR100 Million in EV Mobility Unit

Shakti Pumps (India) (NSE:SHAKTIPUMP, BOM:531431) said it has invested 100 million Indian rupees in its wholly owned subsidiary Shakti EV Mobility by subscribing to 10 million equity shares, according to a Tuesday filing to the Indian stock exchanges.Shares of the company rose 1% in Wednesday's trade.With this, Shakti Pumps' total investment in the EV mobility unit has increased to 650 million Indian rupees, the filing said.The investment is aimed at supporting business expansion of the subsidiary, it added.

$BOM:531431$NSE:SHAKTIPUMP
Asia

Challenger's Fiscal 2026 Q3 Update Missed Consensus Across Key Life Metrics, Jarden Says

Challenger's (ASX:CGF) fiscal 2026 third-quarter update missed consensus across key Life metrics, with FM outflows significantly worse than expected, driven by institutional equity mandate attrition in both Australian and global equities, according to a Tuesday note by Jarden.The firm's redemption of all CGFPC notes on May 25 simplifies the capital structure, reduces the AT1 coupon burden, and is earnings-per-share accretive.Jarden sees balanced risk/reward for Challenger in the future, with catalysts including capital management flexibility from the Australian Prudential Regulation Authority reform, as well as expanding retirement partnerships across superfunds.It lowered its fiscal 2026 sales forecast to reflect weaker institutional fixed-term sales, partially offset by higher retail annuity sales as partnerships come online.The investment firm retained its neutral rating on Challenger and raised the price target to AU$8.70 per share from AU$8.60 per share.

$ASX:CGF
Asia

Proya Cosmetics 2025 Profit Down 4%, Revenue Slips 2%

Proya Cosmetics (SHA:603605) posted 2025 attributable net profit of 1.50 billion yuan, down 3.5% from 1.55 billion yuan the previous year.Earnings per share slid to 3.80 yuan from 3.92 yuan, according to a Wednesday filing with the Shanghai bourse.Operating revenue declined 1.7% year over year to 10.6 billion yuan from 10.8 billion yuan.Shares of the cosmetics maker were up over 1% in recent trade.

$SHA:603605